McLaren Cancer Institute-Northern Michigan is a clinical research site located in Petoskey, Michigan, United States 49770.
Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.
McLaren Cancer Institute-Northern Michigan has participated in 82 clinical trials with 53 currently active.
Therapeutic areas: Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Canal Squamous Cell Carcinoma.
Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Michigan · View every site in Petoskey
Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
McLaren Cancer Institute-Northern Michigan has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
McLaren Cancer Institute-Northern Michigan has 82 clinical trials on record, with 53 currently active. Their work covers Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Canal Squamous Cell Carcinoma.
McLaren Cancer Institute-Northern Michigan has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.